Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors-Reference-Cited by-同舟云学术

Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors

Published:2008-10 Issue:20 Volume:18 Page:5648-5652
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Fucini Raymond V.,Hanan Emily J.,Romanowski Michael J.,Elling Robert A.,Lew Willard,Barr Kenneth J.,Zhu Jiang,Yoburn Joshua C.,Liu Yang,Fahr Bruce T.,Fan Junfa,Lu Yafan,Pham Phuongly,Choong Ingrid C.,VanderPorten Erica C.,Bui Minna,Purkey Hans E.,Evanchik Marc J.,Yang Wenjin

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference17 articles.

1. Polo-like kinases and oncogenesis

2. Structure and function of Polo-like kinases

3. Regulation of cell cycle checkpoints by polo-like kinases

4. Polo-like kinases (Plks) and cancer

5. Targeting polo-like kinase 1 for cancer therapy

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QSAR-guided pharmacophoric modeling reveals important structural requirements for Polo kinase 1 (Plk1) inhibitors;Journal of Molecular Graphics and Modelling;2021-12

2. Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far;Pharmaceutical Sciences;2021-04-24

3. Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications;Journal of Drug Targeting;2020-09-14

4. Recent Progress in the Synthesis of Pyrazolopyridines and Their Derivatives;Organic Preparations and Procedures International;2019-01-02

5. Drug Design for ALK-Positive NSCLC: an Integrated Pharmacophore-Based 3D QSAR and Virtual Screening Strategy;Applied Biochemistry and Biotechnology;2017-11-13